Abstract |
The ruthenium-based drug NAMI-A, characterised by its selectivity against solid tumour metastases, promotes TGF-β1-dependent fibrosis and the reduction of the release of MMPs in the primary tumour. The aim of the study was to examine the interaction of NAMI-A with TGF-β1 in the process of metastasis formation. NAMI-A (1) affects the secretion of TGF-β1 in metastatic MDA-MB-231 cells rather than in non-tumorigenic HBL-100 cells, (2) prevails over TGF-β1 with regard to the invasive capacity of the treated cells, and (3) contrasts integrin-dependent migration stimulated by TGF-β1. It, thus, appears that the effects of NAMI-A on cell invasion and migration are best summarised as an interference with TGF-β1 and a reduction of its activity in these events. At a molecular level, the similar activity of NAMI-A and TGF-β1 on RhoA GTPase supports its interaction with cell surface integrins while TGF-β1 can activate it by interaction with its TGFβR receptor. The inhibition of TGF-β1-induced migration of MDA-MB-231 cells by NAMI-A cannot simply be attributed to a modulation of the Smad2 and p38MAPK pathways. In conclusion, the effects of NAMI-A on the biological role of TGF-β1 in cancer metastasis are insufficient to attribute the responsibility for the anti-metastatic activity of the ruthenium-based drug to this target alone.
|
Authors | L Brescacin, A Masi, G Sava, A Bergamo |
Journal | Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry
(J Biol Inorg Chem)
Vol. 20
Issue 7
Pg. 1163-73
(Oct 2015)
ISSN: 1432-1327 [Electronic] Germany |
PMID | 26369538
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Organometallic Compounds
- Ruthenium Compounds
- Transforming Growth Factor beta1
- imidazolium-bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III)
- Ruthenium
- Dimethyl Sulfoxide
|
Topics |
- Antineoplastic Agents
(chemistry, pharmacology)
- Cell Adhesion
(drug effects)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Dimethyl Sulfoxide
(analogs & derivatives, chemistry, pharmacokinetics, pharmacology)
- Humans
- Molecular Structure
- Neoplasm Metastasis
(drug therapy)
- Neoplasms
(drug therapy, physiopathology)
- Organometallic Compounds
(chemistry, pharmacokinetics, pharmacology)
- Ruthenium
(chemistry, pharmacology)
- Ruthenium Compounds
- Transforming Growth Factor beta1
(metabolism)
|